−139.28 M NOK
848.00 K NOK
102.49 M
About Oncoinvent ASA
Sector
Industry
CEO
Øystein Soug
Website
Headquarters
Bergen
Founded
2007
ISIN
NO0013251173
FIGI
BBG00G6BKT52
Oncoinvent ASA engages in the development of biopharmaceutical product for cancer therapy. It focuses on developing a pipeline of AXL kinase inhibitors. Its lead product bemcentinib, is a selective and orally bio-available small molecule AXL inhibitor. The company was founded by James Bradley Lorens and David R. Micklem on December 21, 2007 and is headquartered in Bergen, Norway.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ONCIN is 1.178 NOK — it has decreased by −1.83% in the past 24 hours. Watch Oncoinvent ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OSL exchange Oncoinvent ASA stocks are traded under the ticker ONCIN.
ONCIN stock has fallen by −9.38% compared to the previous week, the month change is a −21.47% fall, over the last year Oncoinvent ASA has showed a −52.88% decrease.
ONCIN reached its all-time high on Dec 16, 2024 with the price of 4.000 NOK, and its all-time low was 1.102 NOK and was reached on Oct 29, 2025. View more price dynamics on ONCIN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ONCIN stock is 6.11% volatile and has beta coefficient of 1.37. Track Oncoinvent ASA stock price on the chart and check out the list of the most volatile stocks — is Oncoinvent ASA there?
Today Oncoinvent ASA has the market capitalization of 187.97 M, it has increased by 316.14% over the last week.
Yes, you can track Oncoinvent ASA financials in yearly and quarterly reports right on TradingView.
No, ONCIN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 12, 2025, the company has 13 employees. See our rating of the largest employees — is Oncoinvent ASA on this list?
Like other stocks, ONCIN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oncoinvent ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oncoinvent ASA technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oncoinvent ASA stock shows the buy signal. See more of Oncoinvent ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.